• By ICR Secretariat
  • Posted Thursday, September 8, 2022

Novartis’ Bradner steps down as research head amid company shake-up

https://www.biopharmadive.com/news/jay-bradner-novartis-nibr-fiona-marshall/631021/

Jay Bradner is stepping down as head of the Novartis Institutes of BioMedical Research after more than six years steering the Swiss pharmaceutical company’s efforts to reinvigorate its drug research.